In conclusion, this study reports that MAPKAPK5-AS1 expression is upregulated in HCC, and MAPKAPK5-AS1 acts as a tumor promoter to facilitate the proliferation, migration, invasion and EMT process of HCC cells by repressing miR-429 and upregulating ZEB1 expression. This evidence concerns the gene MAPKAPK5 and hepatocellular carcinoma.